HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

NACDS hire will aid Capitol Hill efforts: The National Association of Chain Drugs Stores brings aboard J. Anne Foley as director of political affairs to help engage members in greater political involvement. The Alexandria, Va.-based trade group said Aug. 23 Foley will enhance the organization's fundraising capabilities and improve collaboration between NACDS' political action committee and its state-level efforts. Foley reports to VP of Federal Affairs Paul Kelly. She comes to NACDS from a political program management function at the Credit Union National Association and also worked at the National Mining Association

You may also be interested in...



New Products In Brief

Stridex Naturally Clear adds botanicals: Blistex Inc. extends its alcohol-free acne pad line with the antioxidant benefits of white tea, pomegranate and soy to promote stronger, healthier skin, according to the company. Stridex Naturally Clear pads contain the acne-fighting ingredient salicylic acid and are designed to maximize cleaning coverage, the Oak Brook, Ill.-based firm says May 12. Blistex offers Stridex Naturally Clear in 55-, 70- and 90-count stock-keeping units, at suggested prices ranging from $3.49 to $6.49

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134816

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel